deltatrials
Recruiting EARLY_PHASE1 INTERVENTIONAL 2-arm NCT06318871

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

A Phase 0 Pilot Study of Memory-like Natural Killer (NK) Cell Immune Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Sponsor: Dana-Farber Cancer Institute

Conditions Chromophobe Renal Cell Carcinoma Renal Carcinoma Renal Cell Carcinoma Translocation Renal Cell Carcinoma Urothelial Carcinoma
Interventions Cytokine Induced Memory-like Natural Killer (CIML NK) Cells Interleukin-2 (IL-2)
Updated 9 times since 2024 Last updated: Jan 27, 2026 Started: Aug 28, 2024 Primary completion: Feb 28, 2027 Completion: Jul 28, 2031
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Chromophobe Renal Cell Carcinoma and Renal Carcinoma, this trial is actively recruiting participants. The trial is conducted by Dana-Farber Cancer Institute and has accumulated 9 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Apr 2024 – ~Jun 2024 · 2 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Jun 2025 · 8 months · monthly snapshotRecruiting~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Feb 2026 · 7 months · monthly snapshotRecruiting~Feb 2026 – present · 7 months · monthly snapshotRecruiting

Change History

9 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting EARLY_PHASE1

  2. Jul 2025 — Feb 2026 [monthly]

    Recruiting EARLY_PHASE1

  3. Jun 2025 — Jul 2025 [monthly]

    Recruiting EARLY_PHASE1

  4. Oct 2024 — Jun 2025 [monthly]

    Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Recruiting

  5. Sep 2024 — Oct 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

▶ Show 4 earlier versions

  1. Aug 2024 — Sep 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  2. Jul 2024 — Aug 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  3. Jun 2024 — Jul 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  4. Apr 2024 — Jun 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dana-Farber Cancer Institute
  • Kidney Cancer Association
Data source: Dana-Farber Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations